From Mind To Market - Boehringer Ingelheim

Best fit for your strategic plan
All of the elements required for outsourcing bio-
pharmaceutical development and manufacture,
from high expression system to fill & finish,
can be found within the corporate capabilities
of Boehringer Ingelheim. We take a very flexible
approach in matching our strengths to our part-
ners’ needs. We can be your partner for all phases
of the development and production process, or
Formulation / fill & finish
- Protein-free formulations
- Aseptic filling
(vials, pre-filled syringes)
- Lyophilization
- Inhalative dosage forms
- Labelling and packaging
Quality control / assurance
- Structure elucidation
- Host cell proteins
- DNA contaminants
- Quality control assays
- cGMP compliance system
we have the ability to work with you at specific
stages, whether early or late phase. Whatever
your development and manufacturing objectives
are, Boehringer Ingelheim can provide precisely
what your strategic plan demands. Our skilled
staff with experience in process science and
cGMP is highly motivated to make your product
a success.
Worldwide registration
- Present in 47 nations
- Track record for more than
20 INDs/CTAs
- More than 10 BLAs/MAAs approved
- Contact to regulatory authorities
- Contribution to ICH guidelines
Option of marketing
- Global market research
- Worldwide distribution network
- Worldwide sales forces
- Local presence
- Reimport and pricing strategy
9